Home › NCT06377527

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Adult patients over the age of 18.
2. Patients with a diagnosis of gynecologic mesonephric-like adenocarcinoma (MLA), mesonephric adenocarcinoma (MA), mesonephric carcinosarcoma, or mesonephric-like carcinosarcomas.
3. For patients who provide consent, they must speak and/or read English or Spanish.

Exclusion Criteria:

1. Patients with other subtypes of EACs.
2. Patients who are considered cognitively impaired. Assessment will be obtained based on their need of a Legally Authorized Representative.

About the study

To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.

Sponsor: M.D. Anderson Cancer Center · Participants: 2,000 · Started: Jul 10, 2024

Contact the study team

• Jeffrey How, MD · Phone: 877-632-6789

Official record on ClinicalTrials.gov — NCT06377527

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.